Exponent (NASDAQ:EXPO) CEO Sells $329,422.60 in Stock

Exponent, Inc. (NASDAQ:EXPO) CEO Catherine Corrigan sold 4,930 shares of the company’s stock in a transaction that occurred on Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total value of $329,422.60. Following the sale, the chief executive officer owned 82,753 shares of the company’s stock, valued at $5,529,555.46. This trade represents a 5.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Catherine Corrigan also recently made the following trade(s):

• On Monday, September 15th, Catherine Corrigan sold 4,905 shares of Exponent stock. The stock was sold at an average price of $69.91, for a total value of $342,908.55.
• On Thursday, August 14th, Catherine Corrigan sold 4,896 shares of Exponent stock. The stock was sold at an average price of $71.09, for a total value of $348,056.64.

Exponent Price Performance

Exponent stock opened at $67.50 on Friday. Exponent, Inc. has a 12 month low of $63.81 and a 12 month high of $113.36. The business has a 50 day simple moving average of $69.57 and a 200-day simple moving average of $73.75. The stock has a market capitalization of $3.41 billion, a PE ratio of 33.75 and a beta of 0.91.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. The firm had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.Exponent’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.57 earnings per share. As a group, equities research analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Friday, September 5th were given a $0.30 dividend. The ex-dividend date was Friday, September 5th. This represents a $1.20 annualized dividend and a yield of 1.8%. Exponent’s dividend payout ratio is presently 60.00%.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Institutional Trading of Exponent

Large investors have recently bought and sold shares of the company. Brooklyn Investment Group grew its holdings in Exponent by 10,200.0% in the first quarter. Brooklyn Investment Group now owns 309 shares of the business services provider’s stock valued at $25,000 after purchasing an additional 306 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in Exponent in the second quarter valued at $34,000. HM Payson & Co. grew its holdings in Exponent by 33.9% in the third quarter. HM Payson & Co. now owns 589 shares of the business services provider’s stock valued at $41,000 after purchasing an additional 149 shares during the last quarter. Bessemer Group Inc. grew its holdings in Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock valued at $55,000 after purchasing an additional 346 shares during the last quarter. Finally, SVB Wealth LLC acquired a new stake in Exponent in the first quarter valued at $80,000. Institutional investors and hedge funds own 92.37% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.